Logo

American Heart Association

  2
  0


Final ID: Mo2107

Mechanisms of Healthy Aging in the Prevention of Atrial Fibrillation

Abstract Body (Do not enter title and authors here): Introduction. Atrial Fibrillation (AF) is the most frequent cardiac arrhythmia. AF can lead to severe complications such as myocardial infarction, strokes, and sudden death. With 70% of AF patients aged 65 and older, aging stands as the major risk factor for AF. Our group have recently contributed to reveal that old Wistar rats (20 months) are more susceptible to AF than younger rats (5 months). Interestingly, Lou/c/jall (LOU) rats, a model of healthy aging derived from Wistar rats, can live up to ~35 months old (equivalent to 100 human years). LOU rats have been identified as resistant to age-related diseases such as obesity, hypertension, and neurodegenerative disorders, which are major risk factors for AF. However, the susceptibility of LOU rats to AF have never been reported.

Hypothesis: LOU rats may carry specific molecular adaptations conferring resistance to age-related cardiac remodeling and low AF vulnerability.

Objectives.
Characterize the vulnerability of very old LOU rats (32 months) to AF compared to old Wistar rats (22 months).
Determine the atrial inflammatory profile of LOU rats and identify the molecular adaptations that may explain their resistance to AF

Methods. Male and Female rats were divided into five groups: LOU and Wistar rats of 5 months (young), 20 months (old), and 32 months (very old: LOU/c rats only). AF inducibility was assessed in vivo using transesophageal electrophysiological study and cardiac structure and function were analyzed by in vivo echocardiography. Atrial electrical conduction was examined using ex vivo optical mapping. Histological analyses were performed to assess atrial fibrosis. Additionally, immunoblot analysis, qPCR, and RNA sequencing were employed to investigate the levels of biomarkers involved in atrial inflammation and fibrosis.

Result. Old Wistar rats were more vulnerable to AF than young rats. Old and very old LOU were significantly more resistant to AF than old Wistar animals. LOU rats’ low susceptibility to AF was accompanied with absence of cardiac structural and functional remodeling and low levels of atrial fibrosis compared to old Wistar. Additionally, advanced age did not affect LOU rats’ atrial electrical conduction properties as compared to old Wistar rats.

Conclusion. Promotion of healthy aging conditions mimicking LOU rats’ resistance to cardiac remodeling and reduction of atrial fibrosis may contribute to prevent AF in subjects with pathological aging.
  • Rose, Andrew  ( Montreal Heart Institute and Department of Pharmacology and Physiology of University of Montreal , MONTREAL , Quebec , Canada )
  • Tardif, Jean-claude  ( Montreal Heart Institute and Faculty of Medicine of the University of Montreal , MONTREAL , Quebec , Canada )
  • Morais, Jose  ( McGill University Health Center , Montreal , Quebec , Canada )
  • Ferland, Guylaine  ( Montreal Heart Institute and Faculty of Medicine of the University of Montreal , MONTREAL , Quebec , Canada )
  • Gaudreau, Pierrette  ( CHUM Research Center and Faculty of Medicine of the University of Montreal , MONTREAL , Quebec , Canada )
  • Hiram, Roddy  ( Montreal Heart Institute and Faculty of Medicine of the University of Montreal , MONTREAL , Quebec , Canada )
  • Younes, Rim  ( Montreal Heart Institute and Faculty of Medicine of the University of Montreal , MONTREAL , Quebec , Canada )
  • Xiao, Jiening  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Dasari, Harika  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Altuntas, Yasemin  ( Montreal Heart Institute and Department of Pharmacology and Physiology of University of Montreal , MONTREAL , Quebec , Canada )
  • Xiong, Feng  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Naud, Patrice  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Sirois, Martin  ( Montreal Heart Institute and Department of Pharmacology and Physiology of University of Montreal , MONTREAL , Quebec , Canada )
  • Tanguay, Jean-francois  ( Montreal Heart Institute and Faculty of Medicine of the University of Montreal , MONTREAL , Quebec , Canada )
  • Author Disclosures:
    Andrew ROSE: DO NOT have relevant financial relationships | Jean-Claude Tardif: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amarin:Past (completed) ; Research Funding (PI or named investigator):Boeringher-Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Novo-Nordisk:Active (exists now) ; Consultant:DalCor Pharmaceuticals:Active (exists now) ; Ownership Interest:DalCor Pharmaceuticals:Active (exists now) ; Speaker:Pfizer:Active (exists now) ; Speaker:Pendopharm:Past (completed) ; Speaker:HLS Pharmaceuticals:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Esperion:Active (exists now) ; Research Funding (PI or named investigator):DalCor Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):Ceapro:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Past (completed) | Jose Morais: DO NOT have relevant financial relationships | Guylaine Ferland: No Answer | Pierrette Gaudreau: No Answer | Roddy Hiram: DO NOT have relevant financial relationships | Rim Younes: No Answer | Jiening Xiao: DO NOT have relevant financial relationships | Harika Dasari: No Answer | Yasemin Altuntas: DO NOT have relevant financial relationships | Feng Xiong: No Answer | Patrice Naud: No Answer | Martin Sirois: No Answer | Jean-Francois Tanguay: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

EP Potpourri #2

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Bromodomain-containing protein 4 Mediates TGF-β-induced Smooth Muscle Cell Differentiation

Guo Xia, Olajuyin Ayobami, Mandlem Venkata Kiran Kumar, Sunil Christudas, Hou Yunzhuan, Adeyanju Oluwaseun, Petkar Sana, Qian Guoqing

A RETROSPECTIVE EVALUATION OF RESOURCE UTILIZATION AND OUTCOMES IN PATIENTS USING MOBILE ECG DEVICES FOLLOWING ABLATION FOR ATRIAL FIBRILLATION

Fairman Alix, Loh Alexander, Druml Lauren, Triplett Cynthia, Liu Taylor, Pursnani Seema

More abstracts from these authors:
IL-37 promotes resolution of Right Heart Disease-induced inflammation and atrial fibrillation.

Neuilly Orlane, Tanguay Jean-francois, Tardif Jean-claude, Hiram Roddy, Younes Rim, Mehdizadeh Mozhdeh, Leblanc Charles-alexandre, Xiong Feng, Naud Patrice, Xiao Jiening, Roy Colombe, Sirois Martin

Prophylactic Administration Of Colchicine Mitigates Atrial Fibrillation Vulnerability Post-Catheter Ablation In Rats: Exploring Sex-Specific Variations.

Attia Abir, Tardif Jean-claude, Hiram Roddy, Le Quilliec Ewen, Leblanc Charles-alexandre, Xiong Feng, Naud Patrice, Xiao Jiening, Roy Colombe, Sirois Martin, Aguilar Martin

You have to be authorized to contact abstract author. Please, Login
Not Available